IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: I. Luttichuys who wrote (457)	3/10/1997 6:15:00 PM
From: Brad C. Dunlap	of 1762

Hi Bennett, IMNX released very impressive phase II data at last years College of Rheumatology conference[OCT 96]. Of all the presentations the ACR highlighted 3 companies Idec,IMNX,and AMGN. I believe that IMNX is about as far along as Idec's CE9.1.[phase III]. ALso there was a 13D filed today by Larry Feinberg on behalf of Oracle Partners L.P. He acquired 5.47%[988,600 sh] of Idec. Do you or anyone know if this is the Larry Feinberg who is a strong spokesperson on behalf of the biotech industry for necessary lobbying in Washington D.C to protect biotech interests? For some reason this comes to my attention but I am not sure.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next